Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Oct 15;23(28):9445-51.
doi: 10.1523/JNEUROSCI.23-28-09445.2003.

The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ

Affiliations

The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ

Roberto Ciccocioppo et al. J Neurosci. .

Abstract

Nociceptin/orphanin FQ (N/OFQ), the endogenous ligand of the opioid N/OFQ receptor (NOP), possesses marked functional anti-stress and anti-corticotropin-releasing factor (CRF) actions. We have shown that intracerebroventricular injection of N/OFQ reverses the hypophagic effect induced by stress or by CRF given intracerebroventricularly. To shed new light on the mechanisms involved in the anti-CRF action of N/OFQ, we investigated the ability of N/OFQ to prevent CRF-induced anorexia after microinjection studies into brain areas of potential interest in the control of feeding behavior and coexpressing NOP and CRF receptors. These areas include the bed nucleus of the stria terminalis (BNST), the central amygdala (CeA), the locus ceruleus (LC), the ventromedial hypothalamus (VMH), the paraventricular nucleus (PVN), and the dorsal raphe (DR). The results demonstrated that the anorectic effect of 0.04 nmol of CRF per rat (200 ng per rat) given intracerebroventricularly is reversed by pretreatment with 0.01-0.21 nmol of N/OFQ per rat (25-500 ng per rat) injected into the BNST but not into the CeA, LC, VMH, PVN, or DR. Microinjection of 0.01-0.02 nmol of CRF per site (50-100 ng per site) into the BNST but not into the CeA or the LC induced marked anorexia in food-deprived rats. Pretreatment with 0.01-0.21 nmol of N/OFQ per site (25-500 ng per site) into the BNST also blocked the anorectic action of 0.02 nmol of CRF per site (100 ng per site) given in the same area. Finally, intra-BNST microinjection of 0.01-0.21 nmol of N/OFQ per site (25-500 ng per site) did not modify food intake in either food-sated or food-deprived rats. These data demonstrate that the BNST is involved in the modulation of CRF-induced anorexia, which is prevented by activation of N/OFQ receptors.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Histological reconstruction showing correct (filled circles) and incorrect (filled triangles) placements of cannula tips. Data presented in the figure are representative of only some of the animals used in the study and are indicative of the criteria used for identification of the correct injection sites. Drawing is from the atlas of Paxinos and Watson (1986).
Figure 2.
Figure 2.
Effect of intracerebroventricular (ICV) CRF on food intake in rats deprived of food for 20 hr. Rats (n = 8) were injected intracerebroventricularly with 0.02, 0.04, 0.1, or 0.21 nmol of CRF or its vehicle (Veh) per rat. Access to food was given 20 min after CRF administration, and food intake was measured after 30 and 60 min. **p < 0.01 versus control (Veh). Error bars represent SEM.
Figure 3.
Figure 3.
Effect of direct microinjections of N/OFQ in discrete brain areas on the inhibition of food intake after intracerebroventricular CRF administration in rats deprived of food for 20 hr. A, BNST of rats (n = 9) was injected with 0.01, 0.02, or 0.21 nmol of N/OFQ or its vehicle (Veh) per site 10 min before injection of 0.04 nmol of CRF or its vehicle per rat intracerebroventricularly. CeA (B; n = 8 rats), LC (C; n = 8 rats), VMH (D; n = 8 rats), PVN (E; n = 8 rats), and DR (F; n = 10) were injected with 0.01, 0.02, or 0.21 nmol of N/OFQ or its vehicle per site 10 min before 0.04 nmol of CRF or its vehicle per rat. Access to food was given 20 min after CRF administration, and food intake was measured after 30 and 60 min. **p < 0.01 versus control (Veh + Veh). Error bars represent SEM.
Figure 4.
Figure 4.
Effect of direct microinjections of CRF in discrete brain areas on food intake in rats deprived of food for 20 hr. BNSTs (A; n = 8 rats), CeAs (B; n = 7 rats), and LCs (C; n = 7 rats) were injected with 0.01 or 0.02 nmol of CRF or its vehicle (Veh) per site. Access to food was given 20 min after CRF administration, and food intake was measured after 30 and 60 min. **p < 0.01 versus control (Veh). Error bars represent SEM.
Figure 5.
Figure 5.
Effect of direct microinjections of N/OFQ and CRF into the BNST on food intake in rats deprived of food for 20 hr. BNSTs of rats (n = 6) were injected first with 0.01, 0.02, or 0.21 nmol of N/OFQ or its vehicle (Veh) per site. After 10 min, animals received an intra-BNST injection of 0.02 nmol of CRF or its vehicle per site. Access to food was given 20 min after CRF administration, and food intake was measured after 30 and 60 min. *p < 0.05 and **p < 0.01 versus control (Veh + Veh). Error bars represent SEM.

References

    1. Ceccatelli S, Villar MJ, Goldstein M, Hokfelt T ( 1989) Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress. Proc Natl Acad Sci USA 86: 9569-9573. - PMC - PubMed
    1. Chalmers DT, Lovenberg TW, De Souza EB ( 1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15: 6340-6350. - PMC - PubMed
    1. Ciccocioppo R, Martin-Fardon R, Weiss F, Massi M ( 2001) Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. NeuroReport 12: 1145-1149. - PubMed
    1. Ciccocioppo R, Biondini M, Antonelli L, Wichmann J, Jenck F, Massi M ( 2002) Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198. Psychopharmacology 161: 113-119. - PubMed
    1. Davis M, Whalen PJ ( 2001) The amygdala: vigilance and emotion. Mol Psychiatry 6: 13-34. - PubMed

Publication types

MeSH terms

LinkOut - more resources